Anita D'Souza, MD, discusses an abstract looking at the combination of teclistamab-cqyv, daratumumab, and pomalidomide in 2 ...

Study of frail older adult patients with myeloma showed reduced disease progression and death with a regimen reducing dexamethasone exposure.

Although it was receiving revenue from eight products, royalties from Johnson & Johnson (JNJ) subsidiary Janssen’s ...

Tampa General Hospital (TGH) in the US has launched a new outpatient transplant unit at the TGH Cancer Institute to offer ...

Despite being the second most common haematologic cancer globally, treatment options for multiple myeloma remain limited, with a significant need for new therapies. 1 Multiple myeloma originates i ...

The New Program Enables Patients with Aggressive Cancers to Receive Cell Therapy Treatment Under Outpatient Care The program allows adult patients undergoing Chimeric Antigen Receptor (CAR) T-cell ...

Reolysin is an oncolytic virus commercialized by Oncolytics Biotech, with a leading Phase II program in Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer).

Multiple Myeloma, a cancer of the plasma cells in the bone marrow, is the third most common blood cancer in Europe. Despite recent advanced in treatment that has increased survival, it is still an ...

ALL one Barnsley man wants for Christmas is his independence back...Wayne Hagland, 60, used to walk up to 12 miles a day...

Discover new research highlighting a 57% increased risk of second primary malignancies in cutaneous melanoma survivors, with ...

A new study has found that the use of semaglutide medications, including Wegovy and Ozempic, may help reduce the risk of ...

BAX launches five new injectible products in the United States, thus further strengthening its U.S Pharmaceuticals business ...